Understanding Carbapenemase Gene Transmission in CREC: Evidence from Guangdong Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) represents a growing concern within the global landscape of antimicrobial resistance. As third among Enterobacteriaceae in carbapenem resistance rates in China, CREC poses particular risks due to its ability to acquire and disseminate carbapenemase-encoding genes (CEGs), often resulting in multidrug-resistant phenotypes and limited therapeutic options. The COVID-19 pandemic has further complicated resistance dynamics, with increased antibiotic use and healthcare disruptions potentially accelerating the spread of resistant organisms. However, comprehensive data on the molecular characteristics and transmission patterns of CEGs in CREC, especially during the pandemic, have been limited. To address this gap, Chen et al. (2025) conducted a multi-center study examining CREC isolates from eight teaching hospitals in Guangdong province between December 2022 and June 2024.

Key Innovation from the Reference Study

The central innovation of the reference study lies in its systematic characterization of CEGs—particularly blaNDM-1, blaIMP, and blaKPC-2—across CREC isolates collected during the COVID-19 pandemic. This work not only quantified the prevalence of these resistance genes but also elucidated their genomic localization (chromosomal versus plasmid), horizontal transfer efficiency, and association with mobile genetic elements. By integrating epidemiological surveillance with molecular typing and conjugation assays, the study provides a granular view of transmission dynamics, informing both clinical practice and antimicrobial resistance research.

Methods and Experimental Design Insights

Chen et al. employed a multi-faceted methodology to dissect the genetic and phenotypic landscape of CREC isolates:

• Sample Collection: Fifty-four non-duplicate CREC strains were obtained from diverse departments (notably respiratory medicine) across eight teaching hospitals in Guangdong.
• Genetic Characterization: Variable temperature SDS plasmid elimination and polymerase chain reaction (PCR) assays were used to detect and localize carbapenemase-encoding genes (e.g., blaNDM-1, blaIMP, blaKPC-2).
• Plasmid Conjugation: Conjugation experiments assessed the horizontal transferability of CEGs, with successful transfer confirmed via PCR in recipient strains.
• Mobile Genetic Elements (MGEs): Six MGEs were identified, with ISEcp1 being the most prevalent, supporting the idea of active gene mobility.
• Genotyping: ERIC-PCR and NTSYS software enabled clustering of isolates into 17 genotypes, providing insights into clonal dissemination.
• Phenotypic Resistance: The broth microdilution method evaluated susceptibility to multiple antibiotics, correlating resistance profiles with CEG presence.
• Epidemiological Data: Patient demographics, clinical departments, and specimen categories were analyzed to map detection trends.

Protocol Parameters

• Plasmid elimination temperature cycles: Variable temperature SDS treatment, protocol specifics adapted from standard molecular microbiology workflows for Enterobacteriaceae.
• PCR detection: Use of primers specific to blaNDM-1, blaIMP, and blaKPC-2; recommended cycling conditions align with published carbapenemase detection protocols.
• Conjugation assay: Matings performed at 37°C for 18-24 hours; selection on antibiotic-containing media per standard recipient/resistance marker usage.
• Broth microdilution testing: MICs determined according to CLSI guidelines; results interpreted with reference to current clinical breakpoints for cephalosporins, aminoglycosides, and fluoroquinolones.

Core Findings and Why They Matter

The study's findings reveal several critical features of CEG epidemiology in CREC:

• High prevalence of CEGs: 85.19% of isolates harbored carbapenemase genes, with blaNDM-1 being the most common. Notably, 33.33% carried blaNDM-1 on both chromosome and plasmid; 46.3% had it only on plasmids.
• Efficient horizontal transfer: Plasmid conjugation assays showed a 95.65% success rate for CEG transfer, underscoring the potential for rapid dissemination within and between hospital settings.
• Association with mobile elements: The predominance of ISEcp1 (87.04%) and co-occurrence of up to four MGE types in single isolates suggest active gene mobilization networks underpinning resistance spread.
• Multidrug resistance: CEG-positive strains exhibited significantly higher resistance rates not only to carbapenems but also to cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin compared to CEG-negative strains.
• Genetic diversity and dissemination: Seventeen genotypes were identified, with the most prevalent (types E and G) found across multiple departments and hospitals, highlighting both clonal and horizontal transmission routes.
• Demographic and clinical associations: Higher detection rates of CEGs were observed in male and elderly patients, in respiratory medicine departments, and in sputum samples.

These data point to a landscape of CREC characterized by both high-level resistance and robust gene transfer capacity, raising significant challenges for treatment and infection control.

Comparison with Existing Internal Articles

Several prior internal articles contextualize and extend the findings of Chen et al. (2025):

• "Transmission Dynamics of Carbapenemase Genes in CREC in Guangdong" provides an accessible summary of the reference study, affirming the high prevalence and transferability of blaNDM-1 in CREC and emphasizing the implications for antimicrobial resistance research and hospital epidemiology.
• "Transmission of Carbapenemase Genes in CREC During COVID-19" further highlights the unique challenges posed by the pandemic context, reinforcing the reference study's observations on increased multidrug resistance and plasmid-mediated gene flow.
• For researchers modeling resistance mechanisms or evaluating intervention strategies, "Cefotaxime in AMR Research: Precision, Plasmid Dynamics, and Practicality" discusses the utility of third-generation cephalosporins like Cefotaxime in dissecting plasmid-mediated resistance, aligning with the experimental frameworks used in the reference study.

The convergence of these sources underscores the urgency of developing robust surveillance and laboratory tools to track and mitigate the spread of carbapenemase-producing organisms.

Limitations and Transferability

While the reference study offers a detailed snapshot of CREC epidemiology in Guangdong, several limitations should be considered:

• Geographic and temporal scope: The data are restricted to eight hospitals in one province over an 18-month period; findings may not fully extrapolate to other regions or longer timescales.
• Sample diversity: Although multiple clinical departments contributed samples, the preponderance from respiratory medicine and sputum may bias detection patterns.
• Functional analysis: The focus on gene presence and transfer does not extend to detailed phenotypic or fitness impacts of specific CEGs or MGEs in vivo.

Nevertheless, the molecular and epidemiological approaches used are transferable to other hospital networks and surveillance programs, providing a template for similar investigations into Gram-positive and Gram-negative bacterial infections elsewhere.

Research Support Resources

Replicating or extending the workflows described by Chen et al. (2025) requires reliable microbiological and molecular reagents. For researchers requiring a third-generation cephalosporin antibiotic for antimicrobial resistance research or bacterial infection models, Cefotaxime (SKU BA1012) from APExBIO offers a well-characterized, beta-lactamase-resistant profile suitable for such protocols. Its documented stability and usage parameters can support high-fidelity modeling of plasmid-mediated resistance, as discussed in related literature. Researchers are advised to prepare fresh solutions and adhere to recommended storage and handling conditions to ensure reproducibility.